NorthCrest Asset Manangement’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EPGL
RG
SAM
CDDEC
MGP
NorthCrest Asset Manangement's AZN Position: Q2 2026 in Review
NorthCrest Asset Manangement opened a new position in AstraZeneca (AZN) in Q2 2026: 3,744 shares worth $668K. The stake represents 0.02% of the portfolio and ranks #482 among its holdings. This is a return to the name: NorthCrest Asset Manangement previously reported a position in AZN as recently as Q4 2025.
NorthCrest Asset Manangement first reported a position in AZN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.85M in Q2 2024. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- NorthCrest Asset Manangement held 3,744 shares of AstraZeneca worth $668K as of Q2 2026.
- AstraZeneca was a new NorthCrest Asset Manangement position in Q2 2026.
- AstraZeneca made up 0.02% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #482 holding.
- NorthCrest Asset Manangement first reported a position in AstraZeneca in Q4 2021 and has held it in 18 quarters since.
- NorthCrest Asset Manangement's AstraZeneca position peaked at $1.85M in Q2 2024.
- 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.